Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phthalazone tethered 1,2,3-triazole conjugates: In silico molecular docking studies, synthesis, in vitro antiproliferative, and kinase inhibitory activities
Mohamed A. Abdelgawad, Syed Nasir Abbas Bukhari, Arafa Musa, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106404-106404
Closed Access | Times Cited: 11

Showing 11 citing articles:

Development of new thieno[2,3-d]pyrimidines as dual EGFR and STAT3 inhibitors endowed with anticancer and pro-apoptotic activities
Heba A. Elsebaie, Tarek F. El‐Moselhy, Eman A. El-Bastawissy, et al.
Bioorganic Chemistry (2024) Vol. 143, pp. 107101-107101
Closed Access | Times Cited: 13
Dynamics of small molecule-enzyme interactions: Novel benzenesulfonamides as multi-target agents endowed with inhibitory effects against some metabolic enzymes
Özcan Güleç, Cüneyt Türkeş, Mustafa Arslan, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 759, pp. 110099-110099
Closed Access | Times Cited: 11
Optimization of pyrazole/1,2,4-triazole as dual EGFR/COX-2 inhibitors: Design, synthesis, anticancer potential, apoptosis induction and cell cycle analysis
Nesma M. Kahk, Fatma El Zahraa Ammar Mohamed, Marwa M. Abdelhakeem, et al.
European Journal of Medicinal Chemistry (2025), pp. 117340-117340
Closed Access
Recent Advances and Future Directions on Small Molecule VEGFR Inhibitors in Oncological Conditions
Amandeep Thakur, Mandeep Rana, Anshul Mishra, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116472-116472
Closed Access | Times Cited: 3
The anti‐breast cancer therapeutic potential of 1,2,3‐triazole‐containing hybrids
Juntao Song, Shuai Zhang, Bo Zhang, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 3
Closed Access | Times Cited: 6
Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets
Alia Mushtaq, Peng Wu, Muhammad Moazzam Naseer
Pharmacology & Therapeutics (2023) Vol. 254, pp. 108579-108579
Closed Access | Times Cited: 6
Recent Advances in the Synthesis of Bioactive Glycohybrids via Click-Chemistry
Ram Sagar, Kavita Singh, Rajdeep Tyagi, et al.
SynOpen (2023) Vol. 07, Iss. 03, pp. 322-352
Open Access | Times Cited: 5
New benzimidazole‐oxadiazole derivatives as potent VEGFR‐2 inhibitors: Synthesis, anticancer evaluation, and docking study
Ulviye Acar Çevik, İsmail Çeli̇k, Şennur Görgülü, et al.
Drug Development Research (2024) Vol. 85, Iss. 4
Open Access | Times Cited: 1
Design, Synthesis, Docking Study of Pyrazolohydrazinopyrimidin‐4‐one Derivatives and Their Application as Antimicrobials
Ruba A. Alolayan, Nadia A. A. Elkanzi, Hajer Hrichi, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 5
Closed Access | Times Cited: 3
Mechanism of action of phthalazinone derivatives against rabies virus
Victoire Perraud, Bart Vanderhoydonck, Guillaume Bouvier, et al.
Antiviral Research (2024) Vol. 224, pp. 105838-105838
Open Access
Cytotoxic and Antioxidant Potential of Launaea mucronata Forssk Essential Oil Growing in Northern Saudi Arabia
Ehab M. Mostafa, Ahmed H. El‐Ghorab, Mohammed M. Ghoneim, et al.
Molecules (2023) Vol. 28, Iss. 20, pp. 7025-7025
Open Access | Times Cited: 1
Page 1

Scroll to top